TP53 and neoplasm: We assessed DNA methylation of the tumor and blood-derived samples from 43 women with early-onset breast cancer, across the genomic regions containing the breast and ovarian cancer susceptibility genes BRCA1, BRCA2, PALB2, TP53, ATM, CDH1, CHEK2, FANCM, MLH1, MSH2, MSH6, and PMS2.